Strides Pharma Science Completes US-FDA Inspection, Receives Form 483 with Four Procedural Observations
Published on: Dec. 26, 2025, 7:33 a.m. | Source: scanx.trade
Strides Pharma Science has completed a US-FDA inspection at its USA facility, with the FDA issuing a Form 483 containing four procedural observations. This represents a standard regulatory review process for pharmaceutical companies operating in the US market.
